Podcasts about EHR

In this episode, Dr. Tinu Tadese, Vice President and Enterprise Chief Medical Informatics Officer at Boston Medical Center, discusses the challenges and opportunities of integrating new hospitals, expanding EHR infrastructure, and strengthening informatics teams. She highlights the need to invest in people over technology and shares her vision for cultivating future physician informatics leaders.

This week, Dr. Jeff Langmaid sits down with Gabe from ChiroHD, one of the fastest-growing EHR platforms in chiropractic. Whether you're actively searching for a new EHR or simply curious about how the latest technology can make your practice run smoother, this episode is packed with insights. Gabe shares the story behind ChiroHD's rapid rise. These unique features set them apart—like integrated texting, actionable data, and cutting-edge reporting—and why more and more chiropractors are making the switch. Plus, you'll hear about where healthcare tech is heading, including game-changing AI integrations and robust solutions for both cash and insurance-based clinics. If you're looking to optimize your workflow, drive efficiency, and unlock your practice's potential, you won't want to miss this conversation!Episode Notes: Learn more about ChiroHD and get $500 off onboarding as a listener! Leander Tables- Save $1,000 on the Series 950 Table using the code EBC2025 — their most advanced flexion-distraction tableTurncloud EHR- Minimalist design, without being sparse. Practical, yet elegant. Turncloud's design was to find the most efficient path in a day in the life of a chiropractic office. Connect with their team at www.turncloud.com Patient Pilot by The Smart Chiropractor is the fastest, easiest to generate weekly patient reactivations on autopilot…without spending any money on advertising. Click here to schedule a call with our team.Our members use research to GROW their practice. Are you interested in increasing your referrals? Discover the best chiropractic marketing you aren't currently using right here!

In this episode of the My DPC Story Podcast, Dr. Ricky Haug joins Maryal as they dive into the latest trends in Direct Primary Care (DPC) technology, fresh from the 2025 DPC Summit. The focus is on the "Battle of the EHRs," where Dr. Haug, an experienced DPC physician with a multi-location, multi-provider practice, shares his firsthand insights on choosing and optimizing Electronic Health Records (EHR) systems for DPC clinics. The discussion covers key findings from the DPC Summit's EHR survey, highlighting what features doctors value most, such as ease of use, patient communication, AI integration, and workflow efficiency. The conversation also touches on common challenges, tech stack evolution, patient portal satisfaction, and the importance of adopting DPC-focused solutions to enhance both patient and staff experience. Whether you're launching a new practice or scaling up, this episode provides practical advice for navigating EHR decisions in DPC, making it a must-listen for physicians seeking to streamline operations and improve patient care. For full survey results and resources, visit mydpcstory.com/magazine.Call in with your questions about how the "Big Beautiful Bill" affects HSAs and DPC. LEAVE A VOICEMAIL HERE.Get your copy of ELATION HEALTH'S HOW TO LAUNCH YOUR OWN DPC PRACTICE CHECKLIST. Get a practice audit and 80 FREE hours of VA work for your DPC with Cool Blue VA! Check out the latest Cool Blue VA Episode HERE!Schedule a demo with Cerbo today!Spruce Health: All-In-One Patient CoSupport the showBe A My DPC Story PATREON MEMBER! SPONSOR THE PODMy DPC Story VOICEMAIL! DPC SWAG!FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube

July 31, 2025: Bill Russell, Drex DeFord, and Sarah Richardson preview their upcoming show changes while tackling critical CIO challenges. They discuss "CIO escape rooms"—high-pressure scenarios such as your EHR vendor going out of business or handling a 3 AM security breach. How do healthcare IT leaders navigate the treacherous waters of CEO transitions, and what's the real difference between a wartime and peacetime CIO? The conversation turns to compensation strategy for a hospital system, examining whether geography or specific leadership "phenotype" should drive salary decisions. They explore what CIOs would prioritize with unlimited budgets, from infrastructure overhauls to real-time data platforms, while questioning who truly deserves the CIDO title in an industry where keeping the lights on battles against driving transformation. Key Points:03:45 CIO Challenges and Escape Room Scenarios06:52 New Podcast Channels and Formats14:03 Real-Time Data Governance and ROI15:51 Automation and Patching in Health Systems17:47 Hiring and Compensation for Health System CIOs20:56 The Role and Value of a good CIDOsX: This Week HealthLinkedIn: This Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

In this episode, we break down how Infinx's AR and Denials Management platform integrates with a variety of PM and EHR systems, and what successful implementation looks like from kickoff to go-live. Learn about data flows, client responsibilities, and how AI modeling is customized using historical claims data for optimal recovery predictions.

AI medical scribe technology is changing the game for physicians overwhelmed by administrative tasks and documentation overload. In this episode, we talk with Dr. Tom Kelly, MD — founder and CEO of Heidi Health, an innovative health tech startup using AI to automate clinical documentation and bring joy back to practicing medicine.Dr. Kelly shares his journey from practicing vascular surgery to founding one of Australia's most promising digital health startups. If you're a doctor, clinician, or healthcare administrator searching for a way to automate SOAP notes, reduce EHR time, and improve patient care, this episode is for you.We dive into how AI in healthcare is not just hype. With the rise of GPT-powered clinical tools, physicians can now focus on what truly matters: patient outcomes. Learn how Heidi Health acts as your personal AI documentation assistant, integrating with systems like Epic and Cerner, and offering a secure, compliant solution that's already being adopted by clinics worldwide.Discover:How EHR automation frees up hours of admin time weeklyThe difference between an AI scribe and traditional dictation toolsHow Heidi Health is HIPAA and GDPR compliantThe real-world results physicians are seeing with this toolWhether you're exploring artificial intelligence in medicine, looking for a digital health startup to follow, or seeking tools to reduce burnout, this conversation offers actionable insight tailored to your goals, pain points, and curiosity about where clinical documentation automation is headed.

In this special bonus episode of My DPC Story, Maryal gives a sneak peek into the newest issue of DPC Magazine: The Toolkit from My DPC Story— a jam-packed edition covering everything from the real-life EHR choices of over 200 DPC physicians, to creative strategies for financing your practice, to using your tech tools to support more equitable care. Curious which EHR came out on top in our reader survey? We're not spoiling it here — but you can read all about it at mydpcstory.com/magazine. And if you're attending in person, look for the bright yellow My DPC Story shirts tomorrow to pick up your physical copy of the magazine!Support the showBe A My DPC Story PATREON MEMBER! SPONSOR THE PODMy DPC Story VOICEMAIL! DPC SWAG!FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube

Most health care providers understand the importance of goals-of-care conversations in aligning treatment plans with patients' goals, especially for those with serious medical problems. And yet, these discussions often either don't happen or at least don't get documented. How can we do better? In today's podcast, we sit down with Ira Byock, Chris Dale, and Matthew Gonzales to discuss a multi-year healthcare system-wide goals of care implementation project within the Providence Health Care System. Spanning 51 hospitals, this initiative was recently described in NEJM Catalyst, showing truly impressive results, including an increase from 7% to 85% in goals of care conversation documentation for patients who were in an ICU for 5 or more days. How did they achieve this?  Our guests will share insights into the project's inception and the strategies that drove its success, including: Organizational Alignment: Integrating GOC documentation into the health system's mission, vision, and strategic objectives. Clinical Leadership Partnership: Collaborating with clinical leaders to establish robust quality standards and metrics. Ease of Documentation: Upgrading the electronic health record (EHR) system to streamline the documentation and retrieval of GOC conversations. Communication Training: Conducting workshops based on the Serious Illness Conversation Guide to equip clinicians with the skills needed for impactful GOC conversations. Join us as we explore how these strategies were implemented and learn how you can apply similar approaches in your own healthcare setting.  

In this solo episode, Dr. Kevin Christie explores how to elevate the patient experience by minimizing friction across every touchpoint in the care journey. Framing the patient experience around three pillars—clinical outcomes, service, and hospitality—he zones in on service and introduces a checklist-driven approach to creating a friction-free experience.From online scheduling and prompt communication to streamlined payment systems and staff responsiveness, Dr. Christie outlines best practices and common pitfalls. He shares tips on integrating technology like compatible EHR systems, two-way texting, online paperwork, and welcome videos, plus how to manage the revenue cycle efficiently to avoid insurance-related frustrations.You'll also hear about the value of storing payment information, pre-scheduling full treatment plans, and crafting seamless referral and follow-up systems—all aimed at reducing friction and enhancing retention.He closes with a challenge: audit your practice's friction points and take targeted action.

Tune in to hear how Presbyterian Homes and Services revolutionized their 47-community senior living operation with point-of-sale technology. Aaron interviews Mary Kieffer, traveling nutrition and culinary director, who shares insider insights on implementing comprehensive POS systems across multiple senior care levels. Learn how integrated technology solutions enhance resident safety through EHR connections, streamlining manual processes, and expand beyond dining to salon services, fitness programs, and family engagement portals. This episode reveals practical strategies for senior living operators seeking operational efficiency, revenue optimization, and improved resident experiences through technology integration. Mary provides actionable advice on cross-departmental collaboration, staff training, and leveraging data analytics for better resident care outcomes in today's competitive senior living marketplace.Tips from Trestle is sponsored by:eMenuChoice: https://bit.ly/TFT_eMenuWiseOx: https://bit.ly/TFT_WiseOxBen E Keith Foods: https://bit.ly/TFT_BEKAdvantageTrust GPO: https://bit.ly/TFTAdvTrust#TFT424 #SeniorLiving #HealthcareTech #PointOfSale #SeniorCare #AssistedLiving #HealthcareInnovation #ElderCare #DigitalHealth #ResidentExperience #CommunityDining #SeniorServices #HealthTech #CaregiverSupport #HospitalityTech #SeniorWellness

Send us a textGenerative AI is transforming the way clinicians interact with technology. In this episode, Dr. Holly Urban, VP of Business Development at Wolters Kluwer, joins John Driscoll to discuss how AI, ambient listening tools, and trusted medical content like UpToDate are improving clinical workflows, easing documentation burdens, and making healthcare delivery more precise, efficient, and human-centered.

Welcome solo and group practice owners! We are Liath Dalton and Evan Dumas, your co-hosts of Group Practice Tech. In our latest episode, we clear up misconceptions about what it means to de-identify information under HIPAA. We discuss: What de-identifying actually means under HIPAA The two methods under which PHI can be de-identified The 18 HIPAA identifiers that indicate if information is PHI The difference between de-identified and anonymized data How to spot red flags from EHR vendors to protect PHI, and what questions to ask Opting in or out of AI note services in your EHR Listen here: https://personcenteredtech.com/group/podcast/ For more, visit our website. PCT Resources Article + 18 Identifier List: De-Identified or Not? The Truth About HIPAA, AI, and Client Data PCT's free Group Practice Service Selection Workbook & Worksheets  -- support for selecting HIPAA-secure, effective, and economical services to meet your practice's functionality and operational needs optional accompanying on-demand CE training: Designing a Group Practice's Tech Setup for Success: Effectiveness, HIPAA Compliance, Client Safety, and Efficiency (1 legal-ethical CE credit hour) Group Practice Care Premium weekly (live & recorded) direct support & consultation service, Group Practice Office Hours -- including monthly session with therapist attorney Eric Ström, JD PhD LMHC + assignable staff HIPAA Security Awareness: Bring Your Own Device training + access to Device Security Center with step-by-step device-specific tutorials & registration forms for securing and documenting all personally owned & practice-provided devices (for *all* team members at no per-person cost) +  assignable staff HIPAA Security Awareness: Remote Workspaces training for all team members + access to Remote Workspace Center with step-by-step tutorials & registration forms for securing and documenting Remote Workspaces (for *all* team members at no per-person cost) + more HIPAA Risk Analysis & Risk Mitigation Planning service for mental health group practices -- care for your practice using our supportive, shame-free risk analysis and mitigation planning service. You'll have your Risk Analysis done within 2 hours, performed by a PCT consultant, using a tool built specifically for mental health group practice, and a mitigation checklist to help you reduce your risks.

Seth Hain has spent two decades at Epic, watching the electronic health record evolve from digital filing cabinet to care-delivery platform. Now he thinks the entire stack of software is being re-imagined, only this time it isn't mobile or cloud driving the change, but generative AI.   In a conversation with Keith Figlioli, Hain explains how new tooling, cheaper compute and larger context windows are pushing healthcare toward an “agentic” era, where software can collect context, ask clarifying questions, and tee up next-best actions before the clinician even walks into the room. He argues that the real breakthrough isn't documentation speed-ups, but the chance to embed a learning health system directly into daily workflows. Central to that vision is Cosmos—a dataset of 15 billion encounters from more than 250 health systems that is already powering condition-specific growth charts and real-world evidence studies. The next step: piping those insights back to the bedside at scale.   Yet technology alone won't deliver. Hain and Figlioli dig into: A real “health grid” is starting to form. Hain envisions a network that connects life-science companies, health-system clinicians and tech builders so discoveries can move from bench to bedside without today's data hand-offs and delays. Epic's role is to lower the technical friction, so researchers can spot patterns, then surface the insight inside everyday workflows. The long-term bet: once the pipes are in place, bespoke therapies (even gene treatments) could be developed and delivered in one coordinated loop rather than siloed phases. Agentic AI is rewriting the user interface, not just speeding up notes. Hain argues the shift from cloud/mobile to generative agents is “noticeably different” because large-context models can listen, remember, reason and suggest next steps in real time. That opens the door to smart exam rooms that combine ambient voice, vision and wearables, and to workflows that provide clinicians with a complete picture before they walk in the patient's room. As UI layers splinter, the possibility of deep insights from longitudinal data is becoming reality, and vendors who overlook this shift will quickly fall behind.  AI as a Force Multiplier for a Shrinking Workforce. With demand still rising faster than the workforce can grow, Hain sees AI as a supplement, not a head-count replacement: think follow-up calls, patient triage or ambient documentation that frees staff to practice at the top of their license. But he's clear that hype won't bend the curve; the industry has to measure quality gains, time saved and patient outcomes before claiming ROI. Governance must evolve in parallel so speed doesn't outrun safety or equity and incumbents that ignore this shift do so at their peril. Throughout, Hain balances optimism with realism: the models are improving fast, but value will hinge on measurable outcomes, thoughtful deployment, and collaboration across an industry that often works in silos.  To hear Seth Hain and Keith discuss these topics and more, listen to this episode of Healthcare is Hard: A Podcast for Insiders. 

Send us a textGuest: Dr. Robb Kruklitis, Chief Clinical Officer at Guthrie ClinicHost: Vik PatelIn this episode of This Week in Health Tech, Vik welcomes Dr. Robb Kruklitis, Chief Clinical Officer at Guthrie Clinic. In this episode, Vik sits down with Dr. Robb Kruklitis to explore Guthrie Clinic's innovative remote patient monitoring (RPM) initiative for chronic disease management. The project focuses on centralizing vital signs and biometric data from patients at home—particularly those with conditions like congestive heart failure—to enable timely interventions and reduce readmissions.Dr. Kruklitis shares how this data flows directly into Epic, where nurses monitor dashboards and respond proactively. Guthrie is also developing a remote clinical workforce to support this model. The discussion highlights the need for smarter alerts, predictive analytics, and ultimately, a shift from reactive to proactive care.Vik draws parallels with Tido's MIDR-AI monitoring solution, and the conversation shifts toward the broader future of AI in healthcare. Both agree that the industry's next leap is to fully harness EHR and external data to drive predictive insights, improve scheduling, and support providers with intelligent tools.Dr. Kruklitis ends on an inspiring note, comparing the future of healthcare data use to Moneyball—leveraging diverse data to deliver the right care at the right time and place.Support the showListen to all This Week in Health Tech episodesVik Patel - LinkedInTido Inc. - WebsiteTido Inc. - LinkedIn

What happens when EHR competitors actually work together? In this video, we dive into how MEDITECH is collaborating with rivals Epic and Oracle Health, as well as complementary platforms like PointClickCare in Canada to finally make interoperability useful and usable for frontline clinicians.Allie Anderson, Senior Regulatory Program Manager - Canada and Robert Molloy, Director, Canadian Market and Product Strategy from MEDITECH share how:✅Bi-directional exchange across vendors is already live in Canadian hospitals✅Consolidated patient summaries are helping reduce clinician overload✅Shared infrastructure is streamlining rollouts and cutting back red tapeWhat do you think of these new cross-vendor strategies? Leave a comment below and share your thoughts.

In this episode, I sat down with Dr. Ronn Berrol to unpack how a single hospital pilot became a 21-site success story—not by replacing Epic, but by solving the one thing it couldn't do well: surfacing the right data, at the right time, for the right patients. We dove deep into how high-risk patients can be flagged before they escalate into crisis, and how real-time data sharing across emergency departments can dramatically reduce admissions and improve flow. And the secret ingredient? A clinician champion who didn't wait for a committee to say yes—he created momentum from the floor up.1.Don't Confuse Your EHR with Strategic Insight Tools Dr. Ronn shared how even the best EMRs like Epic can bury clinicians in data. What made a difference wasn't more information—but surfacing the right information at the right time for high-risk patients.2.Champions Create Change, Not Systems Alone Technology alone didn't earn trust. It was the clinicians—like Ronn—who piloted it, saw value, and advocated upward that drove full-scale adoption across 21 hospitals.3.Pilot First, Scale Fast—But Only When It Works Many hospitals hesitate to adopt new solutions unless a clear ROI is shown early. That's why the original pilot funded by a hospital foundation was a turning point.4.Care Coordination Starts Before the Crisis With tools that flag social risks, housing instability, or medication lapses—this platform helped avoid ER boarding by addressing patients' needs before they spiraled.5.Modern Innovation Means Cross-Hospital Collaboration Emergency departments often operate in silos. But the real breakthrough came from sharing real-time patient data across unaffiliated EDs.6.You Don't Need to Solve Everything—Just What Others Miss What made this solution a win wasn't trying to replace Epic—it filled the critical gap Epic couldn't: surfacing actionable insights, fast.Have you ever been the “first yes” that helped an innovation take off in your org?Episode Timeline: 00:01:56 - How piloting EDO began through visibility gaps in local EDs.00:03:51 - Clinical inefficiencies and the importance of care pathways.00:05:50 - Workflow improvements reduced boarding and increased capacity.00:07:53 - How a charitable foundation funded the pilot despite cost concerns.00:09:37 - Dr. Ron contrasts EDO vs Epic and explains its push-not-pull advantage.00:11:17 - EDO pushes key info in 30-45 seconds vs long EHR chart reviews.00:13:42 - How EDO helps solve new CMS and system-wide goals.00:17:26 - Dr. Ron expands on how lack of access causes overreliance on EDs.00:21:48 - Key takeaway #1: EHR ≠ strategic insight tool.00:22:17 - Key takeaway #2: Clinician champions drive change.00:22:31 - Key takeaway #3: Pilot first, scale fast.00:22:47 - Key takeaway #4: Coordinate care before crisis.00:23:13 - Key takeaway #5: Share data across hospitals.00:23:30 - Key takeaway #6: Fill the gap, don't replace the system.

In this episode, host Olivier Lafontaine sits down with Yolanda Austin, Senior Director of the Life & Annuity Program at ACORD, to talk about the organization's role in building smarter, standardized systems for life insurance. Yolanda breaks down how ACORD is addressing inefficiencies in medical underwriting by creating digital formats for electronic health records. She also walks through the work behind ACORD's standardized life insurance application, which was developed with input from distributors, carriers, and the Interstate Insurance Compact. And now, it is being adopted across the industry. As the conversation unfolds, it's clear that progress in this space doesn't come from technology alone, but through thoughtful coordination and collaboration across all parts of the ecosystem. Key Takeaways: Standardization only works when carriers, distributors, and regulators build it together. Reducing redundant and non-relevant data improves efficiency and unlocks smarter underwriting decisions. Creating digital forms that create good experiences requires both technology and behavioral science expertise. Jump Into the Conversation: (00:00) Meet Yolanda Austin (02:28) How ACORD began solving problems in insurance (03:35) Turning Microsoft's data model into an ACORD standard (04:59) Collaborating with DTCC and the Interstate Compact (05:53) From high school co-op to insurance leadership (08:44) Fixing inefficiencies in underwriting with EHR data standards (10:54) How ACORD reduced medical data by 93 percent (13:36) Will AI reshape how underwriters use health records? (15:14) The mission to standardize every life insurance form (19:45) How ACORD got carriers to align on questions (24:37) What e-labels and fillable forms change for insurers   Resources: Connect with Yolanda Austin: https://www.linkedin.com/in/yolandaaustin/  Check out ACORD: https://www.acord.org/  Connect with Olivier: https://www.linkedin.com/in/olivierlafontaine/

We sit down with three distinguished endocrinologists—Dr. Kashif Latif, Dr. Michael James Haller, and Dr. Kevin Kaiserman—to discuss the last 100 years of innovation in diabetes treatment, from starvation diets to modern insulin therapy.  In this episode, we discuss FDA and non-FDA-approved interventions in medical science. Please do not rely on this podcast for medical advice or as a guide for prescribing. The following were mentioned on the podcast, and you should be aware of their side effects and complete indications as prescribed by the FDA.As with any treatment, it's important to understand the potential adverse reactions with TZIELD. Throughout the TN-10 Study, greater incidences of cytokine release syndrome, serious infections, hypersensitivity reactions, and serum sickness, lymphopenia, and neutropenia were reported in TZIELD-treated patients vs placebo-treated patients. Most common adverse reactions (>10%) were lymphopenia, rash, leukopenia, and headache. These are not all the adverse reactions reported with TZIELD. Please see full Important Safety Information and Prescribing Information.AFREZZA can cause serious side effects, including: Sudden lung problems (bronchospasms). In a study, some AFREZZA-treated patients with asthma, whose asthma medication was temporarily withheld, experienced sudden lung problems. Do not use AFREZZA if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD). Before starting AFREZZA, consult your healthcare clinician.Inhale Study Link 01:25 Early Screening and Universal Screening02:18 Dr. Latif's Journey into Endocrinology04:22 Dr. Haller's Path to Pediatric Endocrinology05:09 Dr. Kaiserman's Career in Diabetes Care05:54 The Importance of EHR in Diabetes Management08:21 Project ECHO: Extending Community Health Outcomes15:39 The Evolution of Insulin Therapy24:22 Revolutionizing Diabetes Care with Inhaled Insulin28:19 Refrigeration and Stability of Insulin28:43 Human Insulin and Genetic Engineering30:04 Inhaled Insulin vs. Insulin Pumps31:33 Inhaled Insulin for Type 2 Diabetics32:28 Challenges in Managing Type 1 Diabetes36:23 Preventing and Delaying Insulin Dependency38:53 The Importance of Early Screening50:14 Future of Type 1 Diabetes TreatmentSupport the show

Clinician burnout isn't just a U.S. issue—and Canadian IT leaders are looking for scalable solutions that actually reduce documentation time. In this interview from #eHealth25, Jallel Harrati, SVP at Suki, explains how their AI assistant is being tailored for the Canadian healthcare system—with deep EHR integrations and local support leading the charge.✅ Learn how Suki is prioritizing integration with Canadian EHRs like Epic, Meditech, and Oracle Health to maximize adoption.✅ Hear why their AI is being built to serve both physicians and nurses by automating more than just notes.✅ Discover why their 70% adoption rate in the U.S. has CIOs across Canada taking notice.What do you think about the future of ambient AI tools in hospitals? Leave a comment below and share your perspective. Don't forget to subscribe for more content on AI in healthcare and health IT strategy.Learn more about Suki at https://www.suki.ai/Find more great health IT content at https://www.healthcareittoday.com/

In this insightful episode, Drew Phillips continues the special series on AI in Dentistry with a deep dive into how Next Health is helping practices modernize patient experiences. Kyle Johnson shares his journey from early-stage team member to driving growth and solving some of the biggest challenges in dental technology—especially data integration. They explore why true AI transformation starts with clean, accessible data, how Next Health built tools that connect fragmented practice management systems, and the very real ways this is reducing front office burdens and improving care delivery today.

The Veterans Affairs Department is coming under heightened scrutiny after it emerged that artificial intelligence likely played a role in VA's decisions on which contracts to cut as part of the Trump administration's purported efficiency push.Edward Graham, who covers VA for our partner publication Nextgov/FCW, joins for this episode to break down what is known so far about VA's use of AI in that process and efforts to get more transparency into what unfolded.ProPublica broke the story first on June 6 and published a follow-up June 10.VA is far from alone in making DOGE-related contract cuts since President Trump took office in January, but this storyline at that agency is drawing ire from some lawmakers and contractors who lost work there.Ed takes our Ross Wilkers through the many moving pieces inside VA, so buckle up to gain many insights into this much-sought after customer for many companies in the market.Lawmakers demand review of VA's AI-driven contract cutsDemocrats raise alarm over AI-driven contract cuts at VAFunding for further EHR deployments ‘vitally important,' VA secretary saysDraft proposal looks to put EHR reform measures back on the table

In this episode, Becker's Healthcare speaks with Jim Blondin, Senior Director of Digital Product Strategy at Accredo Specialty Pharmacy, about the strategic benefits of integrating specialty pharmacy into EHR workflows. The discussion explores how this integration can reduce workflow friction, improve care coordination, and enhance both patient and provider experiences. Tune in for insights relevant to pharmacy leaders, CIOs, and healthcare executives navigating digital transformation.This episode is sponsored by Accredo Specialty Pharmacy.

Michael chats with Dr. Michael Docktor, pediatric gastroenterologist, digital health innovator, and CEO of Dock Health. Together, they discuss how AI is reshaping the operational fabric of healthcare. Docktor unpacks common myths about AI's role in clinical settings, explains how Dock powers the invisible but critical workflows between systems, and explores how human-led, AI-supported operations can reduce burnout, improve administrative processes like referrals, and unlock real ROI. He also shares why Dock isn't just another EHR plugin or project tracker—it's a productivity platform purpose-built for the complexity of care delivery.

June 23, 2025: Samme Diaz, Vice President of Advisory Services at Healthlink Advisors, joins Sarah for the news. How can healthcare organizations address the persistent challenge of EHR-driven nurse burnout when clunky interfaces and poor workflow integration continue to hinder their progress? And as Emory Healthcare pioneers the nation's first Apple-powered hospital environment, what possibilities emerge when consumer technology meets clinical care? Beyond the technology itself, Sarah and Samme draw from their CIO experience to examine the often-overlooked human elements of digital transformation. Key Points: 01:43 Nurses and EHR Burnout 06:52 Emory's Apple-Powered Hospital 14:34 Challenges and Opportunities News Articles:  Nurses Continue to Name EHRs a Top Driver of Burnout and Resignation in 2025, Black Book Nurses' Week Survey Emory Healthcare debuts 1st Apple-powered hospital

[SPONSORED] Are AI scribes living up to their hype? Is interoperability finally improving the lives of patients and clinicians? In this video, we dig into how ambient AI and real-world interoperability are giving clinicians time back, reducing documentation stress, and improving care with fewer clicks.Hear directly from Dr. Seth Eaton, Medical Director at MedPeds, as he shares how his team is using eClinicalWorks and tools like Sunoh.ai and healow PRISMA to solve major workflow pain points—without additional burden on staff. You'll learn how AI Scribes is helping catch things doctors miss and how one missed MRI detail led to better care.

Dr. John Sweetenham and Dr. Erika Hamilton highlight key abstracts that were presented at ASCO25, including advances in breast and pancreatic cancers as well as remarkable data from the use of structured exercise programs in cancer care. Transcript Dr. Sweetenham: Hello, and welcome to the ASCO Daily News Podcast. I'm your host, Dr. John Sweetenham. Today, we'll be discussing some of the key advances and novel approaches in cancer care that were presented at the 2025 ASCO Annual Meeting. I'm delighted to be joined again by the chair of the Meeting's Scientific Program, Dr. Erika Hamilton. She is a medical oncologist and director of breast cancer and gynecologic cancer research at the Sarah Cannon Research Institute in Nashville, Tennessee.  Our full disclosures are available in the transcript of this episode. Dr. Hamilton, congratulations on a fantastic meeting. From the practice-changing science to the world-renowned speakers at this year's Meeting, ASCO25 really reflected the amazing progress we're seeing in oncology today and the enormous opportunities that lie ahead of us. And thanks for coming back on to the podcast today to discuss some of these advances. Dr. Hamilton: Thanks, Dr. Sweetenham. I'm happy to join you today. It really was an impactful ASCO Annual Meeting. I probably am biased, but some great research was presented this year, and I heard lots of great conversations happening while we were there. Dr. Sweetenham: Yeah, absolutely. There was a lot of buzz, as well as a lot of media buzz around the meeting this year, and I think that's probably a good place to start. So I'd like to dive into abstract number LBA3510. This was the CHALLENGE trial, which created a lot of buzz at the meeting and subsequently in the media. This is the study that was led by the NCI Canada Clinical Trials Group, which was the first randomized phase 3 trial in patients with stage III and high-risk stage II colon cancer, which demonstrated that a post-treatment structured exercise program is both feasible and effective in improving disease-free survival in this patient group. The study was performed over a long period of time and in many respects is quite remarkable. So, I wonder if you could give us your thoughts about this study and whether you think that this means that our futures are going to be full of structured exercise programs for those patients who may benefit. Dr. Hamilton: It's a fantastic question. I think that this abstract did create a lot of buzz. We were very excited when we read it. It was highlighted in one of the Clinical Science Symposium sessions. But briefly, this was a phase 3 randomized trial. It was conducted at 55 centers, so really a broad experience, and patients that had resected colon cancer who completed adjuvant therapy were allowed to participate. There were essentially 2 groups: a structured exercise program, called ‘the exercise group,' or health education materials alone, so that was called just ‘the health education group.' And this was a 3-year intervention, so very high quality. The primary end point, as you mentioned, was disease-free survival. This actually accrued from 2009 to 2024, so quite a lift, and almost 900 patients underwent randomization to the exercise group or the health education group. And at almost 8 years of follow-up, we saw that the disease-free survival was significantly longer in the exercise group than the health education group. This was essentially 80.3% of patients were disease-free in exercise and 73.9% in the health education group. So a difference of over 6 percentage points, which, you know, at least in the breast cancer world, we make decisions about whether to do chemotherapy or not based on these kind of data. We also looked at overall survival in the exercise group and health education group, and the 8-year overall survival was 90.3% in the exercise group and 83.2% in the health education group. So this was a difference of 7.1%. Still statistically significant. I think this was really a fantastic effort over more than a decade at over 50 institutions with almost 900 patients, really done in a very systematic, high-intervention way that showed a fantastic result. Absolutely generalizable for patients with colon cancer. We have hints in other cancers that this is beneficial, and frankly, for our patients for other comorbidities, such as cardiovascular, etc., I really think that this is an abstract that deserved the press that it received. Dr. Sweetenham: Yeah, absolutely, and it is going to be very interesting, I think, over the next 2 or 3 years to see how much impact this particular study might have on programs across the country and across the world actually, in terms of what they do in this kind of adjuvant setting for structured exercise. Dr. Hamilton: Absolutely.  So let's move on to Abstract 3006. This was an NCI-led effort comparing genomic testing using ctDNA and tissue from patients with less common cancers who were enrolled in but not eligible for a treatment arm of the NCI-MATCH trial. Tell us about your takeaways from this study. Dr. Sweetenham: Yeah, so I thought this was a really interesting study based, as you said, on NCI-MATCH. And many of the listeners will probably remember that the original NCI-MATCH study screened almost 6,000 patients to assess eligibility for those who had an actionable mutation. And it turned out that about 60% of the patients who went on to the study had less common tumors, which were defined as anything other than colon, rectum, breast, non–small cell lung cancer, or prostate cancer. And most of those patients lacked an eligible mutation of interest and so didn't get onto a trial therapy. But with a great deal of foresight, the study group had actually collected plasma samples from these patients so that they would have the opportunity to look at circulating tumor DNA profiles with the potential being that this might be another way for testing for clinically relevant mutations in some of these less common cancer types. So initially, they tested more than 2,000 patients, and to make a somewhat complicated story short, there was a subset of five histologies with a larger representation in terms of sample size. And these were cholangiocarcinoma, small cell lung cancer, esophageal cancer, pancreatic, and salivary gland cancer. And in those particular tumors, when they compared the ctDNA sequencing with the original tumor, there was a concordance there of around 84%, 85%. And in the presentation, the investigators go on to list the specific mutated genes that were identified in each of those tumors. But I think that the other compelling part of this study from my perspective was not just that concordance, which suggests that there's an opportunity there for the use of ctDNA instead of tumor biopsies in some of these situations, but what was also interesting was the fact that there were several clinically relevant mutations which were detected only in the circulating tumor DNA. And a couple of examples of those included IDH1 for cholangiocarcinoma, BRAF and p53 in several histologies, and microsatellite instability was most prevalent in small cell lung cancer in the ctDNA. So I think that what this demonstrates is that liquid biopsy is certainly a viable screening option for patients who are being assessed for matching for targeted therapies in clinical trials. The fact that some of these mutations were only seen in the ctDNA and not in the primary tumor specimen certainly suggests that there's some tumor heterogeneity. But I think that for me, the most compelling part of this study was the fact that many of these mutations were only picked up in the plasma. And so, as the authors concluded, they believe that a comprehensive gene profiling with circulating tumor DNA probably should be included as a primary screening modality in future trials of targeted therapy of this type. Dr. Hamilton: Yeah, I think that that's really interesting and mirrors a lot of data that we've been seeing. At least in breast cancer, you know, we still do a biopsy up front to make sure that our markers, we're still treating the right disease that we think we are. But it really speaks to the utility of using ctDNA for serial monitoring and the emergence of mutations. Dr. Sweetenham: Absolutely. And you mentioned breast cancer, and so I'd like to dwell on that for a moment here because obviously, there was a huge amount of exciting breast cancer data presented at the meeting this year. And in particular, I'd like to ask you about LBA1008, the DESTINY-Breast09 clinical trial, which I think has the potential to establish a new first-line standard of care for metastatic HER2+ breast cancer. And that's an area where we haven't seen a whole lot of innovation for around a decade now. So can you give us some of the highlights of this trial and what your thinking is, having seen the results? Dr. Hamilton: Yeah, absolutely. So this was a trial in the first-line metastatic HER2 setting. So this was looking at trastuzumab deruxtecan. We certainly have had no shortage of reports around this drug, initially approved for later lines. DESTINY-Breast03 brought it into our second-line setting for HER2+ disease and we're now looking at DESTINY-Breast09 in first-line. So this actually was a 3-arm trial where patients were randomized 1:1:1 against standard taxane/trastuzumab/pertuzumab in one arm; trastuzumab deruxtecan with pertuzumab in another arm; and then a third arm, trastuzumab deruxtecan alone. And what we did not see reported was that trastuzumab deruxtecan-alone arm. But we did have reports from the trastuzumab deruxtecan plus pertuzumab versus the chemo/trastuzumab/pertuzumab. And what we saw was a statistically significant improvement in median progression-free survival, 26.9 months up to 40.7, so an improvement of 13.8 months, over a year in PFS. Not to mention that we're now in the 40-month range for PFS in first-line disease. Really, across all subgroups, we really weren't able to pick out a subset of patients that did not benefit. We did see about a 12% ILD rate with trastuzumab deruxtecan. That really is on par with what we've seen in other studies, around 10%-15%. I think that this is going to become a new standard of care in the first-line. I think it did leave some unanswered questions. We saw some data from the PATINA trial this past San Antonio Breast, looking at the addition of endocrine therapy with or without a CDK4/6 inhibitor, palbociclib, for those patients that also have ER+ disease, after taxane has dropped out in the first-line setting. So how we're going to kind of merge all this together is, I suspect that there are going to be patients that we or they just don't have the appetite to continue 3 to 4 years of trastuzumab deruxtecan. And so we're probably going to be looking at a maintenance-type strategy for them, maybe integrating the PATINA data there. But how we really put this into practice in the first-line setting and if or when we think about de-escalating down from trastuzumab deruxtecan to antibody therapy are some lingering questions. Dr. Sweetenham: Okay, so certainly is going to influence practice, but watch this space for a little bit longer, it sounds as though that's what you're saying. Dr. Hamilton: Absolutely.  So let's move on to GI cancer. Abstract 4006 reported preliminary results from the randomized phase 2 study of elraglusib in combination with gemcitabine/nab-paclitaxel versus the chemo gemcitabine/nab-paclitaxel alone in patients with previously untreated metastatic pancreatic cancer. Can you tell us more about this study? Dr. Sweetenham: Yeah, absolutely. As you mentioned, elraglusib is actually a first-in-class inhibitor of GSK3-beta, which has multiple potential actions in pancreatic cancer. But the drug itself may be involved in mediating drug resistance as well as in some tumor immune response modulation. Some of that's not clearly understood, I believe, right now. But certainly, preclinical data suggests that the drug may be effective in preclinical models and may also be effective in combination with chemotherapy and potentially with immune-modulating agents as well. So this particular study, as you said, was an open-label, randomized phase 2 study in which patients with pancreatic cancer were randomized 2:1 in favor of the elraglusib plus GMP—gemcitabine and nab-paclitaxel—versus the chemotherapy alone. And upon completion of the study, which is not right now, median overall survival was the primary end point, but there are a number of other end points which I'll talk about in just a moment. But the sample size was planned to be around 207 patients. The primary analysis included 155 patients in the combination arm versus 78 patients in the gemcitabine/nab-paclitaxel arm. Overall, the 1-year overall survival rate was 44.1% for the patients in the elraglusib-containing arm versus 23.0% in the patients receiving gemcitabine/nab-paclitaxel only. When they look at the median overall survival, it was 9.3 months for the experimental arm versus 7.2 months for chemotherapy alone. So put another way, there's around a 37% reduction in the risk of death with the use of this combination arm. The treatment was overall well-tolerated. There were some issues with grade 1 to 2 transient visual impairment in a large proportion of the patients. The most common treatment-related adverse effects with the elraglusib/GMP combination was transient visual impairment, which affected around 60% of the patients. Most of the more serious treatment-related adverse events included neutropenia, anemia, and fatigue in 50%, 25%, and 16% of the patients, respectively. So the early results from this study show a significant benefit for 1-year overall survival and for median overall survival with, as I mentioned above, a significant reduction in the risk of death. The authors went on to mention that the median overall survival for the control arm in this study is somewhat lower than in other comparable trials, but they think that this may be related to a more advanced disease burden in this particular study. Of interest to me was that right now: there is no apparent difference in progression-free survival between the 2 arms of this study. The authors described this as potentially indicating that this may be related in some way to immune modulation and immune effects on the tumor, which, if I'm completely honest, I don't totally understand. And so, the improvement in overall survival, as far as I can see at the moment, is not matched by an improvement in progression-free survival. So I think we probably need to wait for more time to elapse to see what happens with the study. And so, I think it certainly is an interesting study, and the results are intriguing, but I think it's probably a little early for it to actually shift the treatment paradigm in this disease. Dr. Hamilton: Fantastic. I think we've been waiting for advances in pancreatic cancer for a long time, but this, not unlike others, we learn more and then learn more we don't realize, so. Dr. Sweetenham: Right. Let's shift gears at this point and talk about a couple of other abstracts in kind of a very different space. Let's start out with symptom management for older adults with cancer. We know that undertreated symptoms are common among the older patient population, and Abstract 11002 reported on a randomized trial that demonstrated the effects of remote monitoring for older patients with cancer in terms of kind of symptoms and so on. Can you tell us a little bit about this study and whether you think this approach will potentially improve care for older patients? Dr. Hamilton: Yeah, I really liked this abstract. It was conducted through the Veterans Affairs, and it was based in California, which I'm telling you that because it's going to have a little bit of an implication later on. But essentially, adults that were 75 years or older who were Medicare Advantage beneficiaries were eligible to participate. Forty-three clinics in Southern California and Arizona, and patients were randomized either into a control group of usual clinic care alone, or an intervention group, which was usual care plus a lay health worker-led proactive telephone-based weekly symptom assessment, and this was for 12 months using the validated Edmonton Symptom Assessment System. So, there was a planned enrollment of at least 200 patients in each group. They successfully met that. And this lay health worker reviewed assessments with a physician assistant, who conducted follow-up for symptoms that changed by 2 points from a prior assessment or were rated 4 or greater. So almost a triage system to figure out who needed to be reached out to and to kind of work on symptoms. What I thought was fantastic about this was it was very representative of where it enrolled. There were actually about 50% of patients enrolled here that were Hispanic or Latinos. So some of our underserved populations and really across a wide variety of tumor types. They found that the intervention group had 53% lower odds of emergency room use, 68% lower odds of hospital use than the control group. And when they translated this to actual total cost of care, this was a savings of about $12,000 U.S. per participant and 75% lower odds of a death in an acute care facility. So I thought this was really interesting for a variety of reasons. One, certainly health care utilization and cost, but even more so, I think any of our patients would want to prevent hospitalizations and ER visits. Normally, that's not a fantastic experience having to feel poorly enough that you're in the emergency room or the hospital. And really showing in kind of concrete metrics that we were able to decrease this with this intervention. In terms of sustainability and scalability, I think the question is really the workforce to do this. Obviously, you know, this is going to take dedicated employees to have the ability to reach out to these patients, etc., but I think in value-based care, there's definitely a possibility of having reimbursement and having the funds to institute a program like this. So, definitely thought-provoking, and I hope it leads to more interventions. Dr. Sweetenham: Yeah, we've seen, over several years now, many of these studies which have looked at remote symptom monitoring and so on in this patient population, and many of them do show benefits for that in kinds of end points, not the least in this study being hospitalization and emergency room avoidance. But I think the scalability and personnel issue is a huge one, and I do wonder at some level whether we may see some AI-based platforms coming along that could actually help with this and provide interactions with these patients outside of actual real people, or at least in combination with real people. Dr. Hamilton: Yeah, that's a fantastic point.  So let's talk a little bit about clinical trials. So eligibility assessment for oncology clinical trials, or prescreening, really relies on manual review of unstructured clinical notes. It's time-consuming, it's prone to errors, and Abstract 1508 reported on the final analysis of a randomized trial that looked at the effect of human-AI teams prescreening for clinical trial eligibility versus human-only or AI-only prescreening. So give us more good news about AI. What did the study find? Dr. Sweetenham: Yeah, this is a really, a really interesting study. And of course, any of us who have ever been involved in clinical trials will know that accrual is always a problem. And I think most centers have attempted, and some quite successfully managed to develop prescreening programs so that patients are screened by a health care provider or health care worker prior to being seen in the clinic, and the clinical investigator will then already know whether they're going to be eligible for a trial or not. But as you've already said, it's a slow process. It's typically somewhat inefficient and requires a lot of time on the part of the health care workers to actually do this in a successful way. And so, this was a study from Emory University where they took three models of ways in which they could assess the accuracy of the prescreening of charts for patients who are going to be considered for clinical trials. One of these was essentially the regular way of having two research coordinators physically abstract the charts. The second one was an AI platform which would extract longitudinal EHR data. And then the third one was a combination of the two. So the AI would be augmented by the research coordinator or the other way around. As a gold standard, they had three independent oncology reviewers who went through all of these charts to provide what they regarded as being the benchmark for accuracy. In a way, it's not a surprise to me because I think that a number of other systems which have used this combination of human verification of AI-based tools, it actually ultimately concluded that the combination of the two in terms of chart accuracy was for the most part better than either one individually, either the research coordinator or the AI alone. So I'll give you just a few examples of where specifically that mattered. The human plus AI platform was more accurate in terms of tumor staging, in terms of identifying biomarker testing and biomarker results, as well as biomarker interpretation, and was also superior in terms of listing medications. There are one or two other areas where either the AI alone was somewhat more accurate, but the significant differences were very much in favor of a combination of human + AI screening of these patient charts. So, in full disclosure, this didn't save time, but what the authors reported was that there were definite efficiency gains, and presumably this would actually become even more improved once the research coordinators were somewhat more comfortable and at home with the AI tool. So, I thought it was an interesting way of trying to enhance clinical trial accrual up front by this combination of humans and technology, and I think it's going to be interesting to see if this gets adopted at other centers in the future. Dr. Hamilton: Yeah, I think it's really fascinating, all the different places that we can be using AI, and I love the takeaway that AI and humans together are better than either individually. Dr. Sweetenham: Absolutely.  Thanks once again, Dr. Hamilton, for sharing your insights with us today and for all of the incredible work you did to build a robust program. And also, congratulations on what was, I think, a really remarkable ASCO this year, one of the most exciting for some time, I think. So thank you again for that. Dr. Hamilton: Thanks so much. It was really a pleasure to work on ASCO 2025 this year. Dr. Sweetenham: And thank you to our listeners for joining us today. You'll find links to all the abstracts we discussed today in the transcript of this episode. Be sure to catch up on all of our coverage from the Annual Meeting. You can catch up on my daily reports that were published each day of the Annual Meeting, featuring the key science and innovations presented. And we'll have wrap-up episodes publishing in June, covering the full spectrum of malignancies from ASCO25. If you value the insights you hear on the ASCO Daily News Podcast, please remember to rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.   More on today's speakers: Dr. John Sweetenham   Dr. Erika Hamilton @erikahamilton9   Follow ASCO on social media:  @ASCO on Twitter  ASCO on Bluesky  ASCO on Facebook   ASCO on LinkedIn     Disclosures:     Dr. John Sweetenham:     No relationships to disclose    Dr. Erika Hamilton: Consulting or Advisory Role (Inst): Pfizer, Genentech/Roche, Lilly, Daiichi Sankyo, Mersana, AstraZeneca, Novartis, Ellipses Pharma, Olema Pharmaceuticals, Stemline Therapeutics, Tubulis, Verascity Science, Theratechnologies, Accutar Biotechnology, Entos, Fosun Pharma, Gilead Sciences, Jazz Pharmaceuticals, Medical Pharma Services, Hosun Pharma, Zentalis Pharmaceuticals, Jefferies, Tempus Labs, Arvinas, Circle Pharma, Janssen, Johnson and Johnson   Research Funding (Inst): AstraZeneca, Hutchison MediPharma, OncoMed, MedImmune, Stem CentRx, Genentech/Roche, Curis, Verastem, Zymeworks, Syndax, Lycera, Rgenix, Novartis, Millenium, TapImmune, Inc., Lilly, Pfizer, Lilly, Pfizer, Tesaro, Boehringer Ingelheim, H3 Biomedicine, Radius Health, Acerta Pharma, Macrogenics, Abbvie, Immunomedics, Fujifilm, eFFECTOR Therapeutics, Merus, Nucana, Regeneron, Leap Therapeutics, Taiho Pharmaceuticals, EMD Serono, Daiichi Sankyo, ArQule, Syros Pharmaceuticals, Clovis Oncology, CytomX Therapeutics, InventisBio, Deciphera, Sermonix Pharmaceuticals, Zenith Epigentics, Arvinas, Harpoon, Black Diamond, Orinove, Molecular Templates, Seattle Genetics, Compugen, GI Therapeutics, Karyopharm Therapeutics, Dana-Farber Cancer Hospital, Shattuck Labs, PharmaMar, Olema Pharmaceuticals, Immunogen, Plexxikon, Amgen, Akesobio Australia, ADC Therapeutics, AtlasMedx, Aravive, Ellipses Pharma, Incyte, MabSpace Biosciences, ORIC Pharmaceuticals, Pieris Pharmaceuticals, Pieris Pharmaceuticals, Pionyr, Repetoire Immune Medicines, Treadwell Therapeutics, Accutar Biotech, Artios, Bliss Biopharmaceutical, Cascadian Therapeutics, Dantari, Duality Biologics, Elucida Oncology, Infinity Pharmaceuticals, Relay Therapeutics, Tolmar, Torque, BeiGene, Context Therapeutics, K-Group Beta, Kind Pharmaceuticals, Loxo Oncology, Oncothyreon, Orum Therapeutics, Prelude Therapeutics, Profound Bio, Cullinan Oncology, Bristol-Myers Squib, Eisai, Fochon Pharmaceuticals, Gilead Sciences, Inspirna, Myriad Genetics, Silverback Therapeutics, Stemline Therapeutics

Dr. Jamie Wells is back—and this time, she brought a book. We cover everything from biomedical design screwups to the glorified billing software known as the EHR. Jamie's new book, A Clinical Lens on Pediatric Engineering, is a masterclass in what happens when you stop treating kids like small, drunk adults and start designing medicine around actual human factors. We talk about AI in pediatric radiology, why drug repurposing might save lives faster than biotech IPOs, and the absurdity of thinking one-size-fits-all in healthcare still works.Jamie's a former physician, a health policy disruptor, a bioethicist, an MIT director, and a recovering adjunct professor. She's also a unicorn. We dig into the wonk, throw shade at bad design, and channel our inner Lisa Simpsons. This one's for anyone who ever wondered why kids' hospitals feel like hell and why “make it taste like bubblegum” might be the most important clinical innovation of all time. You'll laugh, you'll learn, and you might get angry enough to fix something.RELATED LINKSJamie Wells on LinkedInBook: A Clinical Lens on Pediatric Engineering (Amazon)Book on SpringerDrexel BioMed ProfileGlobal Blockchain Business CouncilJamie's HuffPost ArticlesFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us a textWhat's the first impression your patients get of your practice? Spoiler alert—it's not your clinical expertise.It's not the credentials on the wall. It's not the sophisticated EHR system you've invested in. It's not even your outcomes data—at least not initially. The first impression starts the moment someone steps through your doors, and it's rooted in an often-overlooked space: your waiting room.Or should I say, what we used to call a waiting room.Today, we're diving into why this space is far more than a holding area. It's your front door of trust, a powerful reflection of how you deliver care—and a golden opportunity to reduce anxiety, elevate patient experience, and even boost the financial health of your practice. If it looks tired or outdated, patients might unconsciously assume your care is, too. If it feels cold and transactional, it primes them to expect the same from your providers. And if it's optimized for comfort, clarity, and calm, it sets the tone for an experience and a relationship grounded in trust.Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill's company, Health e Practices' website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: http://21978609.hs-sites.com/newletter-subscriber Want more content? Find sample job descriptions, financial tools, templates and much more: www.MedicalMoneyMattersPodcast.com  Purchase your copy of Jill's book here: Physician Heal Thy Financial Self Join our Medical Money Matters Facebook Group here: https://www.facebook.com/groups/3834886643404507/ Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig's website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourseven.com/

Endocrinologist Michael Morkos discusses his article "Mastering the art of efficient patient encounters: tips for physicians." Michael shares practical strategies for optimizing the patient encounter to enhance both efficiency and patient satisfaction. He delves into effective documentation techniques, emphasizing the importance of maintaining eye contact while touch-typing in the exam room, and adapting clinic setups with adjustable carts and laptops. Michael explains his system for ordering future labs during visits in lab-heavy specialties like endocrinology, ensuring all necessary data is available for follow-up appointments. He also outlines his streamlined EHR workflow, including pre-charting, side-by-side review of outside records, and transparent patient communication during the visit. Michael highlights how these methods enable him to complete all notes and charges by the end of the day, significantly reducing after-hours work and contributing to burnout prevention. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise—and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Why does your EHR feel more like a burden than a solution? Eugene Shatsman sits down with leaders from RevolutionEHR, Eyefinity, and practicing ODs to discuss the painful realities of optometric software — and what the next generation must do differently.

June 12, 2025: Jennifer Stemmler, Chief Digital and Information Officer at Adventist Health, opens up about orchestrating one of healthcare's largest EHR migrations—transitioning 28 hospitals and 400 clinics from a decades-old Cerner system to Epic. Guided by the mantra "on time, on budget, on Epic, on us," how does she maintain control without micromanaging every decision? When groups push back on standardization or value-based care teams clash with implementation timelines, what framework actually works to resolve conflicts? Jennifer reveals her benefits realization scorecard approach and discusses the real challenge behind any major transformation: how do you ensure the organization owns the change rather than waiting for someone else to save them? Key Points: 03:09 Strategic Planning and Key Objectives 06:25 Guiding Principles and Pre-Planning Phase 17:44 Managing Internal Tensions and Lessons Learned 25:56 Post-Go-Live Success and Future Planning 34:36 Final Thoughts and Advice for Other Health Systems X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

In this episode, Laura Dyrda, Editor-in-Chief at Becker's Healthcare, discusses the latest healthcare stories, including changes to the CDC's vaccine advisory committee, shifts in physician employment trends, and Stanford's pilot of a new AI-powered EHR tool designed to streamline clinician workflows.

In this episode of Quality Matters, Julie Seibert, Assistant Vice President of Behavioral Health at NCQA, joins host Andy Reynolds to explore the rise of—and the relationship between—two trends in behavioral health: measurement-informed care and peer support. Julie breaks down how these strategies improve outcomes, engage patients and close gaps in access and accountability.Listen to this episode to discover: How Measurement-Informed Care Engages Patients: Learn how measurement-informed care supports patient engagement and treatment adjustments in behavioral health. We explore the importance of ongoing assessment, tracking symptoms and outcomes and empowering patients to understand their journey. Friction and Fuel for New Approaches: We unpack historical challenges to measurement-informed care. These include the omission of behavioral health from key legislation and the costs of EHR integration. We also discuss how NCQA depression measures and person-centered outcome measures relate to measurement-informed care.Benefitting From Peers' Lived Experience: We discuss how people who have been through mental health or substance use treatment can provide non-clinical support to help others navigate the system, subvert stigma and fill care gaps.This discussion is a valuable resource for providers, policy leaders and others who care about improving access, engagement and outcomes in behavioral health.Key Quote:"Measurement-based care has been around for a long time and only 20% of behavioral health providers adopted it.Traditionally, these are trained clinicians. And in the course of a session with a patient, probably in the back of their mind, they're evaluating whether an individual is improving or has worsening function.Payers would like some numerical or standardized way of seeing the clinician's clinical judgment. Measurement-informed care offers that."Julie SeibertTime Stamps:(03:04) Who's Behind Measurement-Informed Care(05:08) HEDIS and Measurement-Informed Care(08:13) Person-Centered Outcome Measures in Behavioral Health(09:58) The Power of Peer Support Specialists(11:57) Addressing Workforce Shortages(15:37) Why States Support Peer Support(16:32) Peer Support's Connection to Measurement-Informed CareDive Deeper:Blog: How Peer Support Can Help Close the Gaps in Behavioral HealthcareBlog: Measurement-Based Care in Behavioral HealthQuality Matters Episode 13: Getting Clear About Behavioral HealthConnect with Julie Seibert

In this conversation, Dr. Masoud Nafey shares his unique journey from being an optometrist to becoming a key player in the integration of technology and AI in healthcare. He discusses the challenges and opportunities in building clinics for major corporations, the evolution of electronic health records (EHR), and the potential of AI in transforming patient care. Dr. Nafey emphasizes the importance of understanding customer needs in technology development and explores the complexities of AI, including large language models and the concept of AI hallucinations. He concludes with insights on the future of AI agents in optometry and the necessity of fine-tuning AI systems for specific applications.   -------------------- For our listeners, use the code 'EYECODEMEDIA22' for 10% off at check out for our Premiere Billing & Coding bundle or our EyeCode Billing & Coding course. Sharpen your billing and coding skills today and leave no money on the table! questions@eyecode-education.com https://coopervision.com/our-company/news-center/press-release/coopervision-and-aoa-join-forces-launch-myopia-collective Go to MacuHealth.com and use the coupon code PODCAST2024 at checkout for special discounts  Show Sponsors: CooperVision MacuHealth

The VA is set to resume its electronic health record modernization program in 2026, nearly three years since it was paused in 2023. During the pause, the agency focused on developing a new strategy for deployment to improve success and boost patient safety. VA now plans to jumpstart the program with a focus on functionality and interoperability of the system, Dr. Neil Evans, VA's acting program executive director of VA's Electronic Health Record Modernization Integration Office explains. Evans discusses how this shift in thinking is building the foundation of a stronger, more functional EHR program. He said the EHR rollout will be conducted in “waves,” where geographically connected medical centers will deploy at the same time so that patients who maneuver between them will have their record accessible no matter where they seek care.

The new UI is no UI - How AI is Transforming the EHR and other Core Solutions NextGen Healthcare's CEO David Sides hosts a fascinating conversation with Diane Kaye, chief product officer, and Sanjeev Kumar, PH.D., chief analytics officer. They discuss how the healthtech industry is leveraging AI to remove sources of friction for providers and enable reimagined workflows that lead to better healthcare outcomes for all. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Discover how Mental Health Cooperative (MHC) in Nashville transformed their behavioral health care delivery with the eClinicalWorks 24-hour care module. In this episode, we welcome Megan Isham, Senior Clinical Systems Manager at MHC, who shares their transformative journey and the impact of this tool on their operations. With the growing recognition of behavioral and mental health, it's crucial to understand that delivering mental healthcare involves a broad spectrum of services. From outpatient therapy and counselling to crisis management, detox, and residential programs, each service comes with unique requirements. This podcast dives into how MHC has leveraged these capabilities to enhance their service delivery and improve health outcomes. Megan details how the Behavioral Health (BH) module has streamlined workflows, integrated care episodes, and customized protocols to meet the specific needs of their diverse patient population. She explains how the system's web-based nature allows their field staff to access vital tools in real time, significantly increasing efficiency and care quality. Key highlights include the seamless integration with Pyxis™ for medication management, customizable Progress Notes, and specialized order sets that cater to both inpatient and outpatient needs. Megan also discusses the innovative approaches to patient safety and the efficient management of complex cases through electronic safety plans and real-time census tracking. This episode is packed with valuable insights into how MHC's adoption of the BH module has been a game changer, delivering comprehensive services that truly made a difference.

In this episode of the Scope of Things, host Deborah Borfitz brings you the latest news on AI-recommended precision dosing, organoid drug testing aiding treatment selection for bowel cancer, an AI tool for stratifying lung cancer patients, using HIV drugs to treat Alzheimer's disease, and the potential value of magic mushrooms to remedy the mood symptoms of Parkinson's. Blythe Adamson, international head of outcomes research and evidence generation at Flatiron Health, also joins in to discuss groundbreaking work harmonizing patient-level real-world data across four countries to enable multinational oncology research.  News Roundup CURATE.AI platform Article in Clinical Research News Study in npj Precision Oncology   FORECAST-2 clinical trial News on the Walter and Eliza Hall Institute website AI tool for sorting cancer patients Study in Nature Communications  HIV drugs for Alzheimer's protection Study in Alzheimer's & Dementia “Magic mushrooms” for Parkinson's disease Study in Neuropsychopharmacology Guest Blythe Adamson, Ph.D., international head of outcomes research and evidence generation at Flatiron Health  Flatiron Health enabling multinational oncology researh – article in Bio-IT World  Subscribe to the podcast on Apple Podcasts and leave a review to support the show. Join us at Scope Europe on October 14-15 in Barcelona - use code SOT10 for an additional 10% discount. GUEST BIO Blythe Adamson, PhD, MPH, Head of Outcomes Research and Evidence Generation, International at Flatiron Health & Founder of Infectious Economics Dr. Blythe Adamson is the head of international outcomes research and evidence generation at Flatiron Health.   As a visionary senior leader at Flatiron Health, her team pioneered deep learning language models for extraction of clinical details from EHR documents, breaking the limits of what was possible for humans to do alone. Learning from the experience of millions of patients with cancer, they generate evidence of treatment effectiveness and value used by governments around the world. Dr. Adamson co-invented a patented clinical decision-support tool, enabled by machine learning, that is used by cancer clinics to benefit patients.   She holds degrees in microbiology, epidemiology, and pharmaceutical economics with a focus on infectious disease prevention. Dr. Adamson has held roles at the Bill and Melinda Gates Foundation Institute for Disease Modeling, the NIAID HIV Vaccine Trials Network, and Flatiron Health. The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider's look at clinical research today.

In this episode of IDD Health Matters, Dr. Craig Escudé is joined by Ricardo Ortega and Babar Nawaz of iCare Manager—an innovative electronic health record (EHR) company revolutionizing care for people with intellectual and developmental disabilities (IDD). Together, they explore how technology can improve efficiency, documentation, and most importantly, the quality of care delivered by providers across 25 states and counting. Ricardo and Babar share their insights into the unique challenges of healthcare in the IDD field, such as state-specific compliance, staffing shortages, and underfunding. Learn how iCare Manager was built from the ground up—with direct input from DSPs, nurses, coordinators, and executives—to create a one-stop, user-friendly solution that empowers providers to spend more time supporting individuals and less time on paperwork. The conversation also looks ahead to the future of healthcare technology, highlighting the exciting (and sometimes scary!) potential of artificial intelligence (AI) in automating assessments, generating personalized care plans, and enhancing service delivery—all while preserving the vital human touch. Topics include: The origin and mission of iCare Manager Addressing compliance across state systems EHR systems built by providers, for providers How AI can improve outcomes and efficiency The importance of person-centered planning and funding in the IDD space Whether you're a provider, administrator, or simply passionate about inclusive healthcare, this episode offers powerful insight into how technology and compassion can go hand-in-hand to support people with IDD.

As the nation faces a critical nursing shortage, rural hospitals are often hit hardest. But at Bingham Memorial, Chief Nursing Officer Holly Davis, MBA, BSA, RN, is flipping the script. In this episode, she shares how her team is using EHR-integrated iPhones, streamlining workflows to significantly reduce discharge documentation time by 75%, and putting nurses at the center of decision-making to reduce burnout and boost retention. Discover how a tech-forward, human-first approach is helping empower this Idaho hospital's nursing team.This episode is sponsored by MEDITECH.

The Big Unlock Podcast · Damo Consulting – Podcast – Ep 162 – Priti Patel In this episode, Priti Patel, MD, VP and Chief Medical Information Officer at John Muir Health shares her journey from family physician to CMIO, offering insights into her 23-year tenure and the evolution of clinical informatics. She also talks about key challenges such as change management, the integration of new tools like predictive analytics, and streamlining prior authorization. Dr. Patel discusses the growing role of informatics in healthcare and how collaboration across clinical and IT teams has driven innovation. One of the key highlights at John Muir Health, a community-based health system, is the early adoption of ambient AI technology for clinical documentation, leading to: reduced cognitive load, time savings of up to 30 minutes per note, and enhanced provider-patient interactions. She also emphasizes the critical role of seamless EHR integration in driving adoption, with over 60% of providers now using the tool regularly. Dr. Patel also outlines the organization's enterprise-wide data strategy, including a robust data literacy initiative that's empowering staff at all levels, starting with the C-suite, to make data-driven decisions and improve care quality and operational outcomes. She underscores that aligning digital strategies with organizational priorities—while focusing on improving the clinician and patient experience—is central to sustainable transformation. Take a listen.

This week their guest is Walter “Buzz” Stewart, PhD, MPH, is a distinguished healthcare researcher and entrepreneur, currently serving as CEO and Co-Founder of Medcurio, a company specializing in real-time EHR data integration solutions. With a career spanning over three decades, Dr. Stewart has held pivotal roles in both academic and healthcare institutions. He previously led research and development initiatives at Sutter Health and founded the Center for Health Research at Geisinger Health System, focusing on digital health, advanced analytics, and precision medicine. Dr. Stewart's academic tenure includes faculty positions at Johns Hopkins Bloomberg School of Public Health, where he contributed significantly to neuro-epidemiology research. His extensive publication record and leadership in healthcare innovation underscore his commitment to transforming patient care through data-driven strategies. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

With all of the AI implementation into EHR and EMR systems, there is concern about how providers rely on these AI shortcuts more than ever. Without proper safeguards, accountability, and compliance perimeters, relying on AI could be problematic. Terry discusses the red flags to look for and how to proceed with caution in this new […] The post Did you know AI is integrated into EMRs? appeared first on Terry Fletcher Consulting, Inc..

Protecting Revenue With Safety Nets For Timely Filing Epic go-lives and other EHR transitions can be chaotic, high-stakes operations that push revenue cycle teams to the limit. When claim work queues go unattended—even for a few weeks—organizations can lose millions in timely filing denials. On this episode Stuart Newsome, VP of Marketing at Infinx, welcomes Tadd Miller, AR Manager at Ni2, an Infinx company, to share how his team averted disaster during a major Epic implementation by developing practical, real-world safety nets. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Our main focus today was on nudging critical care clinicians to consider a more palliative approach to care.  Our guests are all trained in critical care: Kate Courtright, Scott Halpern, and Jaspal Singh.  Kate and Scott have additional training in palliative medicine.  To start. we review: What is a nudge? Also called behavioral interventions, heuristics, and cognitive biases. Prior podcasts on the ethics of nudging, and a different trial conducted by Kate and Scott in which the default for hospitalized seriously ill patients was to receive a palliative care consult. What is sludge?  I'd never heard the term, perhaps outside of Eric's pejorative reference to my coffee after adding copious creamers, flavoring, and sweeteners.  Sludge is apparently when you create barriers or extra work for someone.  For example, putting the healthy food at the back of the grocery store is sludge; making an applicant for health insurance climb the flight of stairs to the office - weeding out those less fit - is also sludge.  Prior-auth forms? Sludge. Examples of nudges, some based in health care, others in coffee.  This specific study, published in JAMA Internal Medicine, was conducted in 17 ICUs in North Carolina. Many were community hospitals.  Participants were critically ill and intubated.  Clinicians were randomized to 4 groups: Usual care Prognosis nudge - EHR prompt asking, do you think your patient will be alive in 6 months? This is called a focusing effect Comfort care nudge - EHR prompt asking if they'd offered comfort-focused care. This is called accountable justification - an appeal to standards of care for critically ill patients endorsed by multiple professional societies. Both the prognosis and comfort care nudge. A few key points of discussion: Is an EHR prompt a nudge or sludge?   The intervention was a negative study for the primary outcome, hospital length of stay.  Why?  The prognosis nudge did nothing.  What to make of that? Would you think an EHR nudge to consider prognosis might move the needle, at least on some outcomes? The nudge toward offering comfort care led to more hospice and early comfort-care orders.  Is this due to chance alone, given the multiplicity of secondary outcomes examined?  Or is it a tantalizing finding that suggests a remarkably low cost EHR based nudge might, on a population level, lead to critical care clinicians offering comfort care and hospice more frequently?  Imagine!    -Alex Smith  

In this episode of the Becker's Healthcare Podcast, Jakob Emerson speaks with Beata Piehl, Director of Interoperability Solutions and EHR Integrations at Dexcom, about how continuous glucose monitoring (CGM) data is transforming glycemic management through seamless integration with electronic health records. Beata shares the latest innovations in CGM-to-EHR interoperability, how Dexcom supports both individualized care and population health strategies, and what sets their direct integration apart. Tune in to learn how healthcare providers can better leverage CGM data to improve outcomes and operational efficiency.This episode is sponsored by Dexcom.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com AI partnerships are revolutionizing healthcare by alleviating physician burnout and improving patient care.  In this episode, Pat Williams, CEO of iScribe, and Chad Dodd, Vice President of athenahealth, discuss their partnership and how it is accelerating AI adoption in healthcare. They highlight how iScribe's ambient AI note generation tool, integrated within athenahealth's EHR platform, is reducing documentation time and restoring joy to medical practice. Chad shares results from the 2025 Physician Sentiment Survey, noting a 10% drop in burnout and crediting AI as a key factor, while Pat adds that iScribe users report less EHR time and more same-day encounter rates. Together, they frame this as a pivotal moment for healthcare transformation, with AI enabling better automation, stakeholder collaboration, and improved patient outcomes. Tune in and learn how AI partnerships are transforming healthcare and enhancing the physician-patient experience! Resources: Connect with and follow Pat Williams on LinkedIn. Listen to Pat's previous episode on our podcast here. Follow iScribeHealth on LinkedIn and explore their website. Connect with and follow Chad Dodd on LinkedIn. Follow athenahealth on LinkedIn and explore their website. Listen to Chad's previous episode on our podcast here. Read athenahealth's 2025 Physician Sentiment Survey here.

In this She Slays Replay, Dr. Brian Capra breaks down a common trap that holds practices back: over-reliance on reports. If you've ever felt like your EHR is drowning you in data but not actually helping you run your business, this conversation will hit home. Dr. Capra explains why reports aren't actionable, how they fail to drive accountability, and what today's practices need instead—real-time task delegation and verification systems that work with you, not against you.Listen to the full episode with Dr. Brian Capra: Spotify | AppleFollow Dr. Brian: LinkedInResources:For those interested in building a profitable personal brand in just two hours a week, check out Dr. Lauryn's new membership group Beyond Brick & Mortar!Grab Lauryn's free “Sexy Niche Checklist” from her website.Sign up for the Weekly Slay newsletter!Follow She Slays and Dr. Lauryn: Instagram | X | LinkedIn | FacebookSign up here to receive our monthly associate job postings email.